Recent Cancer Australia grant outcomes

2012

Priority-driven Collaborative Cancer Research Scheme

Beaumont, Kimberley
Centenary Institute of Cancer Medicine and Cell Biology
The role of Rab27a and Rab5a in melanoma phenotype switching
Funded by Cure Cancer Australia Foundation


Colvin, Emily
Kolling Institute of Medical Research
Investigating the tumour-promoting phenotype of cancer-associated fibroblasts in serous epithelial ovarian cancer
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

Grimison, Peter
University of Sydney
Accelerating first-line chemotherapy to improve cure rates for advanced germ cell tumours: an Australian-led, international randomised trial
Funded by Cancer Australia

Hong, Angela
University of Sydney
Improving the outcomes of oropharyngeal cancer: specific human papillomavirus oncoproteins and p53 mutations as modifying factors
Funded by Cure Cancer Australia Foundation

Micklethwaite, Kenneth
Westmead Hospital
Production of off the shelf T-cells expressing a non-MHC restricted CD19 specific chimeric antigen receptor for use in a Phase I study of T-cell therapy of relapsed and refractory B cell malignancies (UNI-T Study)
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

Morton, Rachael
University of Sydney
The cost-effectiveness of adjuvant whole brain radiotherapy for melanoma brain metastases: a trial-based and modelled economic evaluation
Funded by Cancer Australia

Payne, Richard
University of Sydney
Preparation and evaluation of synthetic self-adjuvanting cancer vaccine candidates
Funded by Cure Cancer Australia Foundation

Pearson, Sallie
University of Sydney
The use and impact of high cost targeted cancer medicines: theory and reality
Co-funded by National Breast Cancer Foundation and Cancer Australia

Sjoquist, Katrin
University of Sydney
A Phase II study to evaluate the safety and potential benefit of intraperitoneal (IP) bevacizumab to control symptomatic malignant ascites in patients with chemotherapy resistant ovarian cancers: REZOLVE (ANZGOG-1101)
Funded by Cancer Australia

Tomlinson, Christopher
Children’s Medical Research Institute
Investigating the mechanism of action of the cancer-associated enzyme telomerase using disease linked telomerase mutants
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

2011

Priority-driven Collaborative Cancer Research Scheme

Butow P
University of Sydney
Evaluation of a psychological and educational intervention for fear of cancer recurrence; a cluster randomised controlled trial
Co-funded by beyondblue, National Breast Cancer Foundation and Cancer Australia

Campbell H
Children’s Medical Research Institute
Mechanism of Δ133p53 isoform oncogenicity
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

Ge Y
University of Sydney
Treating deforming tumours with real-time adaptive radiotherapy
Funded by Cure Cancer Australia Foundation

Kiely B
University of Sydney
Evaluation of a web-based tool for estimating and explaining prognosis in advanced cancer
Co-funded by beyondblue and Cancer Australia

McNees K
Children’s Medical Research Institute
The role of single stranded DNA binding proteins in the Alternative Lengthening of Telomeres mechanism
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

Reid G
Asbestos Diseases Research Institute
The use of RNAi to identify new therapeutic targets for malignant mesothelioma
Funded by Cancer Australia

Vardy J
University of Sydney
Ginkgo biloba preserves cognitive function in women treated with adjuvant chemotherapy for early breast cancer: a double-blind, placebo-controlled, randomised phase III trial
Co-funded by beyondblue, National Breast Cancer Foundation and Cancer Australia

2010

Priority-driven Collaborative Cancer Research Scheme

Chen Y
The Children’s Hospital at Westmead
Tumor protein D52 overexpression and DNA repair in cancer
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

Davidson A
University of Sydney – Clinical Trials Centre
NITRO - A randomised, phase III trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer
Funded by Cancer Australia

Fogarty G
University of Sydney
Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma – a randomised phase III trial
Funded by Cancer Australia

Henson J
Children's Medical Research Institute
Alternative Lengthening of Telomeres (ALT) in lung cancer: analysis of effects on patient outcomes and development of a blood test
Co-funded by Cure Cancer Australia Foundation and the National Lung Cancer Program

Hilton H
Westmead Institute for Cancer Research
The impact of aberrant progesterone signalling on lineage specification during early malignant transformation
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

2009

Priority-driven Collaborative Cancer Research Scheme

De Fazio A
Westmead Institute for Cancer Research
Genomic determinants of chemosensitivity in ovarian cancer
Funded by Cancer Australia

Hahn M
Kolling Institute of Medical Research
A link between p53, RNF20 and parafibromin in malignancy
Funded by Cure Cancer Australia Foundation

Horvath L
Sydney Cancer Centre
Identifying and targeting Docetaxel resistance in hormone refractory prostate cancer
Co-funded by Prostate Cancer Foundation of Australia and Cancer Australia

Huang X
University of Sydney
hOGG1 in human skin carcinogenesis
Co-funded by Cure Cancer Australia Foundation of Australia and Cancer Australia

Napier C
Children’s Medical Research Institute
Ku: a potential repressor of the ALT telomere maintenance mechanism
Funded by Cure Cancer Australia Foundation of Australia

Pickett H
Children’s Medical Research Institute
Telomere trimming: a novel mechanism for preventing unlimited cellular proliferation
Co-funded by Cure Cancer Australia Foundation of Australia and Cancer Australia

Soon P
Kolling Institute of Medical Research
The role of microRNAs in the progression of ductal carcinoma in situ to invasive breast cancer
Co-funded by Cure Cancer Australia Foundation of Australia and Cancer Australia

Trevena L
University of Sydney
Randomised trial of consumer-led familial cancer risk tool & GP triage on risk-appropriate colorectal cancer screening
Funded by Cancer Australia

2008

Priority-driven Collaborative Cancer Research Scheme

Kilbreath S
Incidence and risk factors for lymphoedema secondary to breast cancer: a prospective cohort study
Co-funded by the National Breast Cancer Foundation and Cancer Australia

Kilbreath S
Clinical correlates of lymphoedema
Funded by the National Breast Cancer Foundation

Markus A
Genome-wide analysis of pre-mRNA splicing regulation by RBM4
Co-funded by Cure Cancer Australia Foundation and Cancer Australia

Olver I
Understanding the psychosocial sequelae of surviving testicular cancer
Co-funded by beyondblue and Cancer Australia

Young J
Quality of life outcomes and cost effectiveness of pelvic exenteration for people with advanced rectal cancer
Co-funded by Cancer Council Australia and Cancer Australia

2007

Priority-driven Collaborative Cancer Research Scheme

Kilbreath S
Prevention of osteoporosis as a consequence of hormone treatment in postmenopausal women treated for breast cancer
Co-funded by Cancer Australia and the National Breast Cancer Foundation

Price T
Preop chemoradiotherapy&postop chemo with capecitabine&oxaliplatin vs. capecitabine alone in locally advanced rectal cancer
Funded by Cancer Australia